·
2 MIN READ

AMA urges participation in Prescription Drug Take Back Day

Doctors are urging their patients to participate in National Prescription Drug Take Back Day by taking unused and expired medicine to drop-off sites.

Press Releases
·
2 MIN READ

AMA welcomes CDC’s revised view on opioids guidelines

The AMA continues to urge informed prescribing to reduce opioid-related harm and appreciates the CDC recognizes that patients require individualized care.

Press Releases
·
2 MIN READ

Arkansas sets standard for states by removing prior authorization for treatment of opioid use disorder

The AMA and AMS commended Governor Asa Hutchinson and the General Assembly for removing administrative barriers to treatment for opioid use disorder (OUD).

Press Releases
Elizabeth Salisbury-Afshar, MD, MPH
·
4 MIN READ

Anyone can save a life with naloxone: What patients should know

The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.

Overdose Epidemic
·
2 MIN READ

April 18, 2019: Advocacy spotlight on FDA and CDC issue clarifications on opioid prescribing guidelines

Get the latest FDA and CDC clarifications on opioid prescribing guidelines. Find out how AMA continues to advocate against the misapplication of CDC guideline.

Advocacy Update
·
6 MIN READ

April 18, 2019: National Advocacy Update

Causes of surprise billing, ambulatory blood pressure monitoring and more in the latest AMA national health care advocacy news.

Advocacy Update
·
2 MIN READ

April 18, 2019: State Advocacy Update

District of Columbia, New Jersey take steps to save lives and more in AMA's latest news on state health care advocacy.

Advocacy Update
·
2 MIN READ

AMA supports FDA’s changes to prescription opioids labels

AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.

Press Releases
·
1 MIN READ

AMA applauds congressional action on prescription drug transparency

The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward.

Press Releases